BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31276464)

  • 1. Use of Topical Steroids in Conjunctivitis: A Review of the Evidence.
    Holland EJ; Fingeret M; Mah FS
    Cornea; 2019 Aug; 38(8):1062-1067. PubMed ID: 31276464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
    Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
    Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
    Sheppard JD; Comstock TL; Cavet ME
    Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
    Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
    Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of inflammation in the cornea and conjunctiva.
    Leibowitz HM
    Ophthalmology; 1980 Aug; 87(8):753-8. PubMed ID: 7443202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indication-prescription study for the management of conjunctivitis in a Colombian population.
    Valladales-Restrepo LF; Machado-Duque ME; Gaviria-Mendoza A; López-Caicedo DF; Ospina-Cano JA; Oyuela-Gutiérrez MC; Martínez-Pulgarín DF; Machado-Alba JE
    Int Ophthalmol; 2023 Jan; 43(1):83-93. PubMed ID: 35776393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.
    Belfort R; Gabriel L; Martins Bispo PJ; Muccioli C; Zacharias Serapicos PC; Clark L; Bell B; Bartell J; Stroman DW; Höfling-Lima AL
    Adv Ther; 2012 May; 29(5):416-26. PubMed ID: 22562783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human conjunctivitis. II. Treatment.
    Leibowitz HM; Pratt MV; Flagstad IJ; Berrospi AR; Kundsin R
    Arch Ophthalmol; 1976 Oct; 94(10):1752-6. PubMed ID: 184771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
    Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
    Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of conjunctivitis].
    Barabási Z
    Orv Hetil; 2004 Oct; 145(41):2107-10. PubMed ID: 15586586
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of seasonal allergic conjunctivitis: guide to therapy.
    Bielory BP; O'Brien TP; Bielory L
    Acta Ophthalmol; 2012 Aug; 90(5):399-407. PubMed ID: 22067457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.
    Wilkins MR; Khan S; Bunce C; Khawaja A; Siriwardena D; Larkin DF
    Br J Ophthalmol; 2011 Sep; 95(9):1299-303. PubMed ID: 21252084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-allergic eosinophilic conjunctivitis].
    Kari O; Saari KM; Haahtela T
    Duodecim; 2010; 126(10):1145-50. PubMed ID: 20597344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis.
    O'Brien TP
    Adv Ther; 2012 Jun; 29(6):473-90. PubMed ID: 22729919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for conjunctivitis.
    Origlieri C; Bielory L
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):523-36. PubMed ID: 19708819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
    Koçluk Y; Sukgen EA; Cevher S; Mat E
    Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
    Chang MH; Fung HB
    Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis.
    Bielory BP; Perez VL; Bielory L
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):469-77. PubMed ID: 20720489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Naclof in the treatment of chronic non-infectious conjunctivitis].
    Pitrová S; Handlová R
    Cesk Slov Oftalmol; 1996 Feb; 52(1):15-9. PubMed ID: 8653625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.